Zebra Imaging Analytics Engine
Zebra’s Imaging Analytics Engine receives imaging scans from various modalities and automatically analyzes them for a number of different clinical findings, in a timely manner and full synergy with radiology workflow. Providers use Zebra-Med to alert them of patients at high risk of cardiovascular, lung, bone and other diseases. This facilitates preventative care programs, proper risk adjustments and allocation, as well as conformance with quality standards such as MACRA. With Zebra-Med – focus can be provided to the right patients, at the right time – saving overall costs while improving care.
Learn more
DeLorean AI Medical AI
Medical AI is a true technology solution that comprehensively addresses chronic diseases. The hallmarks of this technology are its ability to predict, generate the next-best actions, and present the outputs in an easy-to-consume user experience. DeLorean Medical AI augments human capabilities and creates a future where we can trust both the machine and the human to make the best decisions. Our technology has been shown to improve outcomes and is the first AI to be biologically validated through third-party clinical tests. With the ability to better classify patient populations, assign risk, and predict disease state transitions, Medical AI directly leads to earlier detection and diagnosis of diseases. It can also reduce costs. Having been installed for 10+ clients, it has demonstrated both cost reductions and savings associated with real-time predictions to determine at-risk populations and next-best-action recommendations based on statistical probabilities.
Learn more
Elucid
Deliver personalized patient care with the only histologically validated, objective, and quantitative CTA-based arterial analysis software. Utilize ground-truth histology to visualize the source of myocardial ischemia and inform heart attack and stroke risk. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated. Current non-invasive testing cannot visualize the biology deep inside artery walls where heart disease develops. Elucid is harnessing scientific imaging and artificial intelligence to enable quick, accurate, noninvasive diagnoses and precise treatment of cardiovascular disease to enable better patient outcomes. Assess plaque composition with histology-validated software. Quantify heart attack and stroke risk with greater accuracy. Visualize a comprehensive and objective view of arterial disease to enable personalized treatment plans before a patient ever enters the hospital.
Learn more
Oncoustics
Oncoustics is creating and deploying advanced and patented AI solutions for low-cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical needs. Oncoustics offers a suite of disease and anatomy-focused apps that work on any PoC ultrasound and can be used by any MD/nurse/tech as a basic primary care office instrument, without the need to look at images. Oncoustics’ AI solutions turn the inexpensive point-of-care ultrasound devices into powerful diagnostic tools for faster, cost-effective detection and monitoring of diseases including diseases in the liver, prostate, kidney, breast, and thyroid. Our team is made up of experts in AI, signal processing, radiology, hepatology, digital health, and ultrasound. Inexpensive point of care diagnosis and surveillance improves outcomes through early detection and monitoring resulting in effective disease management.
Learn more